BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Immunicon Corporation 

3401 Masons Mill Road
Suite 100
Huntingdon Valley  Pennsylvania  19006  U.S.A.
Phone: 215-830-0777 Fax: 215-830-0751


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Suppliers






 Company News
Veridex, LLC Completes Acquisition of Immunicon Corporation (IMMC) Assets 8/4/2008 9:17:42 AM
Immunicon Corporation (IMMC) Files for Chapter 11 Bankruptcy 6/11/2008 6:27:37 AM
Immunicon Corporation (IMMC) to Present at 2008 American Society of Clinical Oncology Annual Meeting 5/30/2008 10:06:30 AM
Immunicon Corporation (IMMC) Presented Advances in Rare Cell Technology at ISAC XXIV International Congress, May 17-21, 2008 5/22/2008 8:49:32 AM
Immunicon Corporation (IMMC) Announces Quotation of Common Stock on Over-the-Counter Bulletin Board 4/29/2008 9:50:16 AM
Immunicon Corporation (IMMC) Receives Grant to Develop Test for Residual Disease in Leukemia Patients 4/23/2008 9:39:16 AM
Immunicon Corporation (IMMC) to Introduce Repeat-Free(TM) Poseidon(TM) FISH Probes And Present Workshop and Posters at 2008 American Association for Cancer Research Annual Meeting 4/9/2008 9:07:40 AM
Immunicon Corporation (IMMC) Announces Availability of Fluorescence In-Situ Hybridization Product Portfolio 4/8/2008 8:56:41 AM
Immunicon Corporation (IMMC) Announces Receipt of Notice from NASDAQ and "Going Concern" Opinion 4/7/2008 9:44:19 AM
Immunicon Corporation (IMMC) is Considering Strategic Alternatives; Including the Sale of Some or All of its Businesses 4/7/2008 9:30:51 AM
12345678910...